Issued Guidance Regarding Telehealth Waivers During the COVID-19 Pandemic

White and Williams LLP
Contact

This document describes guidance issued during, or in response to, the COVID-19 crisis which impacts the provision of medical treatment via technological means (generally referred to as “telehealth” or “telemedicine”). It is not intended as overall guidance on legal issues related to telehealth, but instead as a resource for navigating changes that have occurred due to the pandemic. Some items listed are limited in scope or duration.

Further, the guidance and regulation of telehealth matters is changing rapidly. We will periodically update this document on our website, as appropriate, to include additional developments. This document is not intended as legal advice. It is important to obtain specific legal advice as to individual facts and circumstances prior to taking any action based on the guidance described.

Please see full publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© White and Williams LLP | Attorney Advertising

Written by:

White and Williams LLP
Contact
more
less

White and Williams LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide